Format

Send to

Choose Destination
Am J Hematol. 2019 Dec;94(12):E322-E325. doi: 10.1002/ajh.25630. Epub 2019 Oct 2.

Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.

Author information

1
Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
2
Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
3
Department of research and development, Geno-Immue Medical Institute, Shenzhen, China.
4
School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
5
Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, Florida.
PMID:
31489688
DOI:
10.1002/ajh.25630

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center